MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejca.2020.12.028

Медицинская библиотека · European journal of cancer (Oxford, England : 1990) · 2021

Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis.

Esposito Angela, Marra Antonio, Bagnardi Vincenzo, Frassoni Samuele, Morganti Stefania, Viale Giulia, Zagami Paola, Varano Gianluca M, Buccimazza Giorgio, Orsi Franco, Venetis Konstantinos, Mazzarella Luca, Viale Giuseppe, Fusco Nicola, Criscitiello Carmen, Curigliano Giuseppe

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

We performed a multi-parametric analysis investigating the association between adiposity (as measured using body mass index [BMI] and computed tomography [CT]-based body composition), tumour infiltrating lymphocytes (TILs) and clinical outcomes in patients with advanced-stage cancer treated with immunotherapy in phase I clinical trials.

MATERIAL AND

METHODS

All consecutive patients (N = 153) with metastatic solid tumours treated within immunotherapy-based phase I clinical trials between August 2014 and May 2019 at our institution were included. Baseline characteristics, BMI, TILs value and CT-assessed fat indices (total fat area [TFA], subcutaneous fat area [SFA] and visceral fat [VFA]) were collected. The primary endpoints were to evaluate the impact of these parameters on overall survival (OS) and progression-free survival (PFS). Kaplan-Meier method and Cox proportional-hazards model were used for survival analyses.

RESULTS

At both univariate and multivariate analyses, BMI was not associated with PFS neither when considered as continuous variable (HR 0.90, 95% CI 0.74-1.09, P = 0.28) nor as dichotomous variable (underweight/normal versus overweight/obese) (HR 0.79, 95% CI 0.55-1.14, P = 0.21). Interestingly, patients diagnosed with 'immunogenic' tumours and higher VFA/SFA ratio (1st and 2nd tertile versus 3rd tertile) presented an increased OS (HR 0.88, 95% CI 0.78-1.00, P = 0.047).

CONCLUSION

Our analysis showed that patients with tumours that are already known as responsive to ICIs with higher VFA/SFA ratio presented an increased OS. Further studies are needed to elucidate the effect of adiposity on the host immune response to immunotherapy.

Для цитирования: Esposito Angela, Marra Antonio, Bagnardi Vincenzo, Frassoni Samuele, Morganti Stefania, Viale Giulia, Zagami Paola, Varano Gianluca M, Buccimazza Giorgio, Orsi Franco, Venetis Konstantinos, Mazzarella Luca, Viale Giuseppe, Fusco Nicola, Criscitiello Carmen, Curigliano Giuseppe. Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis.. European journal of cancer (Oxford, England : 1990). 2021. DOI: 10.1016/j.ejca.2020.12.028.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.